uniQure N.V. Accounts Receivable, Related Parties, Current
uniQure N.V. (QURE) had Accounts Receivable, Related Parties, Current of $223.00 thousand as of 2020-09-30, per its 10-Q filed 2020-10-27.
Discontinued › Notes
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2021-03-01
- 2020-09-30: Accounts Receivable, Related Parties, Current $223.00K.
- 2020-06-30: Accounts Receivable, Related Parties, Current $222.00K.
- 2020-03-31: Accounts Receivable, Related Parties, Current $258.00K.
- 2019-12-31: Accounts Receivable, Related Parties, Current $947.00K.
| Period end | Accounts Receivable, Related Parties, Current |
|---|---|
| 2020-09-30 | $223.00K 10-Q · filed 2020-10-27 |
| 2020-06-30 | $222.00K 10-Q · filed 2020-07-30 |
| 2020-03-31 | $258.00K 10-Q · filed 2020-04-29 |
| 2019-12-31 | $947.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $101.00K 10-Q · filed 2019-10-28 |
| 2019-06-30 | $355.00K 10-Q · filed 2019-07-29 |
| 2019-03-31 | $461.00K 10-Q · filed 2019-04-29 |
| 2018-12-31 | $233.00K 10-K · filed 2020-03-02 |
| 2018-09-30 | $552.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.04M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.06M 10-Q · filed 2018-04-30 |
| 2017-12-31 | $1.59M 10-K · filed 2019-02-28 |
| 2017-09-30 | $1.95M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $1.63M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $517.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $5.50M 10-K · filed 2018-03-14 |
| 2015-12-31 | $4.13M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |